SWAVUnknown
Shockwave Medical, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Shockwave Medical, Inc. (SWAV), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are SWAV insiders buying or selling?
Shockwave Medical, Inc. insiders reported 1 open-market buys ($510.0K) and 240 sells ($623.4M) across 241 Form 4 filings — a net selling position of $622.9M.
Source: SEC EDGAR Form 4
Key Statistics (as of Mar 28, 2024)
Total Form 4 filings
241
SEC EDGAR
Insider filers
13
Insider buys (1)
$510.0K
Insider sells (240)
$623.4M
Insider sentiment
Net sellingNet insider flow of $622.9M in net selling.
Recent SWAV insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 28, 2024 | Laura Francis | Director | Sale | 1.5K | $300.00 | $450.0K |
| Mar 28, 2024 | Isaac Zacharias | President, CCO | Sale | 4.0K | $287.67 | $1.2M |
| Mar 8, 2024 | Frank T Watkins | Director | Sale | 2.0K | $253.65 | $507.3K |
| Mar 7, 2024 | Trinh Phung | VP, Finance | Sale | 21 | $253.14 | $5.3K |
| Feb 28, 2024 | Isaac Zacharias | President, CCO | Sale | 4.0K | $260.36 | $1.0M |
| Feb 23, 2024 | Frederic H Moll | Director | Sale | 60.0K | $257.39 | $15.4M |
| Feb 23, 2024 | Trinh Phung | VP, Finance | Sale | 599 | $259.24 | $155.3K |
| Feb 21, 2024 | Laura Francis | Director | Sale | 1.0K | $250.00 | $250.0K |
| Feb 17, 2024 | Douglas Evan Godshall | President & CEO | Sale | 10.0K | $231.56 | $2.3M |
| Feb 8, 2024 | Trinh Phung | VP, Finance | Sale | 1.3K | $232.18 | $298.8K |
| Feb 8, 2024 | Frank T Watkins | Director | Sale | 2.0K | $231.76 | $463.5K |
| Feb 7, 2024 | Dan Puckett | Chief Financial Officer | Sale | 3.2K | $231.15 | $746.4K |
| Feb 3, 2024 | Dan Puckett | Chief Financial Officer | Sale | 3.4K | $229.76 | $782.6K |
| Jan 30, 2024 | Isaac Zacharias | President, CCO | Sale | 4.0K | $224.69 | $898.8K |
| Jan 19, 2024 | Douglas Evan Godshall | President & CEO | Sale | 10.0K | $217.59 | $2.2M |
| Jan 11, 2024 | Frank T Watkins | Director | Sale | 2.0K | $198.99 | $398.0K |
| Jan 9, 2024 | Douglas Evan Godshall | President & CEO | Sale | 10.0K | $200.05 | $2.0M |
| Dec 29, 2023 | Isaac Zacharias | President, CCO | Sale | 4.0K | $192.50 | $770.0K |
| Dec 19, 2023 | Douglas Evan Godshall | President & CEO | Sale | 5.0K | $187.80 | $939.0K |
| Dec 12, 2023 | Dan Puckett | Chief Financial Officer | Sale | 200 | $173.88 | $34.8K |
| Dec 9, 2023 | Trinh Phung | VP, Finance | Sale | 203 | $171.63 | $34.8K |
| Nov 29, 2023 | Isaac Zacharias | President, CCO | Sale | 4.0K | $173.58 | $694.3K |
| Nov 22, 2023 | Frank T Watkins | Director | Sale | 3.0K | $173.35 | $520.0K |
| Nov 18, 2023 | Douglas Evan Godshall | President & CEO | Sale | 5.0K | $174.08 | $870.4K |
| Oct 31, 2023 | Isaac Zacharias | President, CCO | Sale | 4.0K | $210.25 | $841.0K |
Showing the 25 most recent of 241 Form 4 filings for Shockwave Medical, Inc..
Most active SWAV insiders
- Isaac Zacharias55 filings
- Dan Puckett43 filings
- Frank T Watkins42 filings
- Antoine Papiernik31 filings
- Douglas Evan Godshall28 filings
Ask anything about SWAV insider activity
Use Trabud's AI agent to query Shockwave Medical, Inc.'s Form 4 history in plain English — "Show me SWAV CEO purchases this year" or compare it against any other ticker.
Open the AI agentSWAV insider trading FAQ
Are Shockwave Medical, Inc. insiders buying or selling?
Across 241 SEC Form 4 filings, Shockwave Medical, Inc. (SWAV) insiders reported 1 open-market purchases totaling $510.0K and 240 sales totaling $623.4M. That is a net selling position of $622.9M.
How many insiders trade SWAV stock?
13 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Shockwave Medical, Inc.. The most recent filing was accepted on Mar 28, 2024.
Where does Trabud get SWAV insider trading data?
All SWAV insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.